Nov 17, 2020
AlzeCure publishes its interim report for January - September 2020
Nov 12, 2020
AlzeCure receives approval to start clinical Phase I trial with ACD856 in Alzheimer's disease
Nov 11, 2020
Poster presentation with the Alzstatin platform now available on AlzeCure's website
Nov 11, 2020
Poster presentation with ACD856 in Alzheimer's now available on AlzeCure's website
Sep 28, 2020
AlzeCure Pharma provides a scientific update on Alzheimer's disease and the Alzstatin project platform
Aug 25, 2020
AlzeCure publishes its interim report for January - June 2020
Jun 04, 2020
AlzeCure Announces Positive Data From Clinical Study with ACD856
May 14, 2020
Doctoral Thesis in Alzheimer's Awarded Best Thesis 2019 at Sahlgrenska Academy
Apr 30, 2020
A New Doctoral Thesis in Alzheimer's Presented Today by AlzeCure Pharma and Karolinska Institutet
Apr 15, 2020
AlzeCure Pharma Publishes its Annual Report for 2019
Mar 16, 2020
AlzeCure Pharma to Present Late Breaking Abstract at the AAT-AD/PD Conference (Advances in Alzheimer's and Parkinson's Therapies)
Jan 08, 2020
Martin Jönsson Appointed New CEO of AlzeCure Pharma
Jan 07, 2020
AlzeCure Pharma Conducts Strategic Inlicensing of Clinical Phase Drug Candidate for Neuropathic Pain
Dec 20, 2019
AlzeCure Initiates Clinical Trial With ACD856
Aug 22, 2019
AlzeCure Publishes its Interim Report for January - June 2019
Apr 15, 2019
AlzeCure Publishes its Annual Report for 2018
Mar 25, 2019
AlzeCure to Present at International Scientific Conference
Mar 20, 2019
AlzeCure Initiates New Drug Project Within Pain